Qianlutong Biotechnology Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Qianlutong Biotechnology General Information

Description

Developer of innovative drug designed to treat nocturia. The company focuses on developing drugs, treatment methods, traditional Chinese medicine for male benign prostatic hyperplasia, genital herpes, providing advanced medical solution for male.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 12, 3rd Floor, Building A, No. 1480, North Section of Tianfu Avenue
  • Chengdu High-tech Zone, China Free Trade Pilot Zone
  • Chengdu, Sichuan 610000
  • China
+86 177
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • No. 12, 3rd Floor, Building A, No. 1480, North Section of Tianfu Avenue
  • Chengdu High-tech Zone, China Free Trade Pilot Zone
  • Chengdu, Sichuan 610000
  • China
+86 177

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Qianlutong Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 08-Jan-2024 Completed Generating Revenue
2. Later Stage VC 30-Jun-2023 Completed Generating Revenue
1. Early Stage VC 01-Jan-2019 Completed Generating Revenue
To view Qianlutong Biotechnology’s complete valuation and funding history, request access »

Qianlutong Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qianlutong Biotechnology Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Qihuang Technology Corporation Minority
Sichuan New Hope Real Estate Development Corporation Minority
GX Pharma Corporation Minority
To view Qianlutong Biotechnology’s complete investors history, request access »

Ready to get started?

Request a free trial

Qianlutong Biotechnology FAQs

  • When was Qianlutong Biotechnology founded?

    Qianlutong Biotechnology was founded in 2017.

  • Where is Qianlutong Biotechnology headquartered?

    Qianlutong Biotechnology is headquartered in Chengdu, China.

  • What is the size of Qianlutong Biotechnology?

    Qianlutong Biotechnology has 2 total employees.

  • What industry is Qianlutong Biotechnology in?

    Qianlutong Biotechnology’s primary industry is Drug Discovery.

  • Is Qianlutong Biotechnology a private or public company?

    Qianlutong Biotechnology is a Private company.

  • What is Qianlutong Biotechnology’s current revenue?

    The current revenue for Qianlutong Biotechnology is .

  • Who are Qianlutong Biotechnology’s investors?

    Qihuang Technology, Sichuan New Hope Real Estate Development, and GX Pharma have invested in Qianlutong Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process